ALGN

Align Technology Inc

ALGN, USA

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

https://www.aligntech.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
ALGN
stock
ALGN

Align Tech (ALGN) Receives a Hold from UBS The Globe and Mail

Read more →
ALGN
stock
ALGN

1 Profitable Stock to Research Further and 2 We Ignore Yahoo Finance

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$180.4667

Analyst Picks

Strong Buy

8

Buy

3

Hold

6

Sell

1

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Medium

33.23

Low 50

High 10

Price to Book Ratio (P/B)

-

Very High

3.06

Low 1

High 3

Return on Equity (ROE)

-

Very Low

1.43 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

0.91 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

High

12.27 %

Low 5%

High 15%

Debt to Equity

-

High

0.58

Low 1

High 0.3

Investors

* Institutions hold a combined 78.79% of the total shares of Align Technology Inc

1.

Vanguard Group Inc

(11.3719%)

since

2025/06/30

2.

BlackRock Inc

(7.0734%)

since

2025/06/30

3.

State Street Corp

(4.0385%)

since

2025/06/30

4.

Vanguard Total Stock Mkt Idx Inv

(2.9884%)

since

2025/07/31

5.

Wellington Management Company LLP

(2.9874%)

since

2025/06/30

6.

Ninety One UK Limited

(2.6437%)

since

2025/06/30

7.

T. Rowe Price Investment Management,Inc.

(2.5415%)

since

2025/06/30

8.

Geode Capital Management, LLC

(2.4622%)

since

2025/06/30

9.

Vanguard 500 Index Investor

(2.3277%)

since

2025/07/31

10.

Citadel Advisors Llc

(2.3088%)

since

2025/06/30

11.

Vanguard Small Cap Index

(2.3065%)

since

2025/07/31

12.

Capital Research & Mgmt Co - Division 3

(2.2307%)

since

2025/06/30

13.

Vanguard Health Care Inv

(2.178%)

since

2025/06/30

14.

FMR Inc

(1.8545%)

since

2025/06/30

15.

Capital World Investors

(1.7892%)

since

2025/06/30

16.

JPMorgan Chase & Co

(1.5444%)

since

2025/06/30

17.

Amvescap Plc.

(1.5037%)

since

2025/06/30

18.

Vanguard Small Cap Value Index Inv

(1.4844%)

since

2025/07/31

19.

Federated Hermes Inc

(1.2785%)

since

2025/06/30

20.

T. Rowe Price US Mid-Cap Growth Equity

(1.2114%)

since

2025/06/30

21.

T. Rowe Price Mid-Cap Growth

(1.2092%)

since

2025/07/31

22.

American Funds New Perspective A

(1.1957%)

since

2025/06/30

23.

Capital Group New Perspective Comp

(1.1957%)

since

2025/06/30

24.

Fidelity 500 Index

(1.1915%)

since

2025/07/31

25.

Disciplined Growth Investors Inc

(1.1657%)

since

2025/06/30

26.

SPDR® S&P 500® ETF

(1.138%)

since

2025/08/31

27.

NORGES BANK

(1.1316%)

since

2025/06/30

28.

iShares Core S&P 500 ETF

(1.1308%)

since

2025/08/31

30.

Veritas Investment Partners (UK) Ltd.

(1.0865%)

since

2025/06/30

31.

Bank of America Corp

(1.0852%)

since

2025/06/30

32.

Morgan Stanley - Brokerage Accounts

(1.0538%)

since

2025/06/30

33.

Invesco S&P 500® Equal Weight ETF

(1.0517%)

since

2025/08/29

34.

Ninety One Global Franchise

(1.0361%)

since

2025/03/31

35.

Ninety One GSF Glb Frchs I Acc USD

(1.0361%)

since

2025/05/31

36.

American Funds Growth Fund of Amer A

(1.0186%)

since

2025/06/30

37.

Capital Group Growth Fnd of Amer Comp

(1.0186%)

since

2025/06/30

38.

The Health Care Select Sector SPDR® ETF

(0.6419%)

since

2025/08/31

39.

Virtus KAR Mid-Cap Core I

(0.5865%)

since

2025/06/30

40.

Vanguard Institutional Index I

(0.5678%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

2.97

Latest Release

Date

2025-09-30

EPS Actual

2.61

EPS Estimate

2.4

EPS Difference

0.21

Surprise Percent

8.75%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(7.3)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(3)
Momentum
Strong Momentum(7)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(6)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.